A quiet revolution is unfolding in crop protection. RNA interference, the cellular gene-silencing mechanism that earned a Nobel Prize in 2006, has finally crossed the threshold from laboratory proof ...

Benitec will present interim clinical results from the ongoing BB-301 Phase 1b/2a study as a late-breaking poster presentation, which will encompass 12-month follow-up data for all six Cohort 1 ...

ALNY fell 4.60% to $235.38 from $246.74 the previous trading day Weiss Ratings assigns C (Hold) Market cap is $34.00B Alnylam ...

ADARx Pharmaceuticals upsized its IPO and raised additional cash through a private placement with partner AbbVie.

A brief history of Arbutus Biopharma◾️A company that began with RNA medicine technologyTechnical roots from Inex to TekmiraTo ...

MeHello, Gemini🐶Do you know what this means?Shin Nippon Biomedical Laboratories surged, and I read the reason displayed on Google Finance, but I didn't really understand it🥺The background to today's ...

The average one-year price target for Alnylam Pharmaceuticals, Inc. - Depositary Receipt (BOVESPA:A1LN34) has been revised to R$105.31 / share. This is an increase of 10.26% from the prior estimate of ...

The world's banana supply faces a severe threat from fungus. Researchers are developing gene-edited, disease-resistant bananas, with some nearing commercial deployment.

Gene Autry, the “Singing Cowboy” whose “Rudolph the Red-Nosed Reindeer” sold more than 30 million copies, died. 2001 – NATO ...

Arrowhead (ARWR) targets sHTG with plozasiran vs. Ionis, showing 79–81% TG cuts and strong liquidity. Read here for a ...

American researchers have shown a previously overlooked structure could provide novel insights into the mechanisms underlying ...

A protein long dismissed as little more than a biological pantry shelf in the fruit fly has turned out to be one of the most intriguing new characters in the biology of aging. In a study published in ...